• Rare-disease-day

    EORTC: Advancing research and treatment for rare cancers

  • 20-year-fellowship-report
    Categories: ,

    EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Categories:

    Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • EORTC EMA workshops
    Categories: ,

    Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • Ravina-Trial

    EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • IMMUcan abstracts at ESMO Immuno-Oncology 2023

    Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

    EORTC Quality of Life measures integrated in CDISC

  • ATOM study
    Categories: ,

    EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma